Julia Stieglmaier

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Radical Prostatectomy

Long Non Coding Rna

Prostate Cancer

Mesenchymal Stem Cells

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

William Kevin Kelly, Daniel Costin Danila, Chia-Chi Lin, Jae Lyun Lee, Nobuaki Matsubara, Patrick J Ward, Andrew J Armstrong, David W Pook, Miso Kim, Tanya Barauskas Dorff, Stefanie Fischer, Yung-Chang Lin, Lisa G Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M Smith, Jamie N Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J Appleman
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer discovery (2023)
Olivier Nolan-Stevaux, Cong Li, Lingming Liang, Jinghui Zhan, Juan Estrada, Tao Osgood, Fei Li, Hanzhi Zhang, Ryan Case, Christopher M Murawsky, Bram Estes, Gregory L Moore, Matthew J Bernett, Umesh S Muchhal, John R Desjarlais, Binnaz K Staley, Jennitte L Stevens, Keegan S Cooke, Famke Aeffner, Oliver Thomas, Julia Stieglmaier, Jae Lyun Lee, Angela Coxon, Julie M Bailis
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer. Cancer discovery (2023)